beta-Adrenoceptor antagonists: new drugs and new indications.
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D001262:Atenolol / Q000494:pharmacology; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007700:Kinetics; D008790:Metoprolol / Q000494:pharmacology / Q000627:therapeutic use; D008881:Migraine Disorders / Q000517:prevention & control; D009248:Nadolol; D010869:Pindolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use; D013999:Timolol / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D009248:Nadolol; D001262:Atenolol; D013999:Timolol; D011433:Propranolol; D010869:Pindolol; D008790:Metoprolol